Neuronal Gabapentin Capsule 75 mg (Pregabalin)

Adult dose

This medication should be administered orally in divided doses twice daily, irrespective of meals. 1. Neuropathic Pain - Peripheral Neuropathic Pain: As a starting dose, 150 mg should be administered daily with the possibility of increasing to 300 mg within 3 to 7 days, and if needed, further increases up to a maximum of 600 mg daily can be made at intervals of 7 days. - Central Neuropathic Pain: As a starting dose, 150 mg should be administered daily, increasing to 300 mg after one week

Child dose

Safety and efficacy data are insufficient for children under 12 years of age and adolescents aged 12 to 17, so administration is not recommended.

This medication may increase the risk of suicidal thoughts or actions, so mood or behavior changes should be closely monitored during treatment. Patients with hypersensitivity to this medication or certain genetic disorders such as lactose intolerance should not take it. Diabetic patients should be cautious as weight gain may affect blood glucose control. If symptoms of angioedema occur, medication should be stopped immediately. Elderly patients should be careful about the risk of falling due to dizziness or drowsiness. Visual disturbances or changes in vision may occur during treatment, so if any unusual symptoms arise, consult a healthcare professional. Withdrawal symptoms such as insomnia, headaches, or anxiety may occur upon discontinuation of the medication, so abrupt cessation should be avoided and follow healthcare provider instructions. Due to the risk of drug abuse, patients with a history of substance abuse should use this medication more cautiously. Patients with heart disease or severe congestive heart failure require special attention when taking this medication. When taken with opioid analgesics, the risk of central nervous system depression increases, so caution is advised when used together. Patients with respiratory diseases, renal impairment, or elderly individuals may require dose adjustments due to severe respiratory depression risks. Pregnant women should avoid using this medication during early pregnancy due to the risk of fetal malformations, and women of childbearing age should ensure effective contraception. Breastfeeding women should consider discontinuing either breastfeeding or the medication as it can be transmitted through breast milk. Before driving or operating hazardous machinery, check for dizziness or drowsiness due to this medication for safety. Serious skin reactions such as Stevens-Johnson syndrome may occur, so if any skin abnormalities appear, discontinue use immediately and consult a healthcare professional. In case of overdose, symptoms such as confusion, drowsiness, or seizures may occur, requiring immediate medical attention for appropriate treatment. This medication should be kept out of the reach of children, and care should be taken to avoid transferring it to other containers, which may cause accidents.

Serious side effects

Hives, severe swelling (angioedema, facial swelling), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, mucosal pain in the mouth/eyes, Stevens-Johnson syndrome, toxic epidermal necrolysis, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities with cough and fever, yellowing of the skin or eyes (jaundice), extreme fatigue throughout the body, sudden and severe

Mild side effects

• Dizziness
• drowsiness
• confusion
• disorientation
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is best to maintain a storage temperature between 15 degrees and 30 degrees Celsius. This will help maintain the medication's effectiveness and safety.

Appearance

Hard capsules with a reddish brown upper part and a white lower part containing a white or light yellow powder

Package unit

30 capsules/bottle, 100 capsules/bottle